BeOne Medicines AG Share Price & Technical Analysis
ONC · $310.3 (+0.20%)
Healthcare / Biotechnology
$310.3
+0.20%
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatme…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
5% return in May, -7% avg return in past 3 year May month.
6% return in 2026, 18% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 12% | -5% | -3% | -3% | 5% | – | – | – | – | – | – | – | 6% |
| 25 | 23% | 23% | 6% | -8% | -5% | -1% | 23% | 6% | 3% | -9% | 10% | -10% | 63% |
| 24 | -16% | 9% | -5% | -2% | -3% | -4% | 15% | 16% | 18% | -9% | 4% | -14% | 10% |
| 23 | 11% | -13% | -8% | 18% | -13% | -19% | 20% | -2% | -14% | 3% | 1% | -3% | -19% |
| 22 | -9% | -12% | -12% | -20% | -12% | 18% | 5% | 5% | -20% | 27% | 9% | 15% | -6% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Uptrend · Uptrend
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; SYLVANT for the treatment of adult patients with multicentric castleman disease; BAITUOWEI for patients with BC in premenopausal and perimenopausal women, and cancer; and PARTRUVIX for the treatment of various solid tumors. Its clinical stage products comprise Sonrotoclax BGB-11417, a small molecule Bcl-2 inhibitor; BGB-16673, a BTK targeting chimeric degradation activation compound active against wild type and mutant BTK; BG-60366, an EGFR-targeted CDAC; BG-89894 (SYH2039), a MAT2A Inhibitor; BGB-58067, an MTA-Cooperative PRMT5 Inhibitor; BG-T187 and BG-C0902, an anti-EGFRxMET trispecific antibody; BGB-26808, a HPK-1 Inhibitor; BGB-C354, an anti-B7H3 ADC; Zanidatamab, a bispecific HER2-targeted antibody; BG-C137, an anti-FGFR2b ADC; BGB-53038, a Pan-KRAS Inhibitor; BGB-B2033, an anti-GPC3x4-1BB bispecific antibody; BGB-B3227, an anti-MUC1xCD16A bispecific antibody; BG-C477, an anti-CEAADC; BGB-43395, a CDK4 Inhibitor; BG-68501, a CDK2 Inhibitor; BG-C9074, an anti-B7H4 ADC; BGB-21447, a Bcl-2 Inhibitor; and BGB-45035, an IRAK4-targeted CDAC. It also has various preclinical programs. The company has agreements Amgen, BMS, Bio-Thera, EUSA Pharma, Luye Pharmaceutical, and Novartis. The company was formerly known as BeiGene, Ltd. and changed its name to BeOne Medicines AG in May 2025. BeOne Medicines AG was founded in 2010 and is based in Basel, Switzerland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$32.48B
P/E ratio
70.99
52W high
$385.2
52W low
$235.4
Volume
1,90,918
Beta
0.50
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is BeOne Medicines AG share price today?
- BeOne Medicines AG (ONC) last traded around $310.3 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ONC have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ONC. Download the app for real-time alerts.
- How can I analyze BeOne Medicines AG stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.